TAK 044 Chemical Properties

Sequence

cyclo({d-Asp}-{α-amino-γ-oxo-4-phenyl-1-piperazinebutanoyl-Asp}-Asp-{d-(2-thienyl)glycine}-Leu-{d-Trp}) (disodium salt)

TAK 044 Usage And Synthesis

Description

TAK-044 is an Endothelin receptor antagonist. TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats. TAK-044 showed protective effect on neuronal cell viability in in vitro oxygen-glucose deprivation model of stroke.

Uses

TAK 044 is an antagonist of Endothelin Receptor. TAK 044 strongly inhibits ET-induced deterioration in various animal models. TAK 044 can be used in study ET-related diseases such as acute myocardial infarction,acute renal failure, acute hepatic malfunction, and subarachnoid hemorrhage[1].

References

[1] Toshifumi Watanabe, et al. TAK-044: An Endothelin Receptor Antagonist. , 14(1), 36–46.

TAK 044(157380-72-8)Related Product Information

• D-ASPARTIC ACID ALPHA-AMIDE HYDROCHLORIDE
• TAK 044
• Piperazine, 1-(3-amino-1-oxopropyl)- (9CI)
• 1,4,7,10,13,16-HEXAAZACYCLOOCTADECANE
• H-D-ALA-BETA-ALA-OH